FLSmidth has been informed that Novo Holdings A/S on behalf of the Novo Nordisk Foundation has reduced its holding of FLSmidth shares to a total of 5,100,000 FLSmidth & Co. A/S shares, which corresponds to 9.95 per cent of the total nominal share capital in FLSmidth & Co. A/S.